| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,088,400 | 1,103,800 | 1,053,000 | 1,205,100 | | Cost of Revenue | 835,700 | 856,200 | 844,200 | 958,400 | | | Gross Profit | 252,700 | 247,600 | 208,800 | 246,700 | | | Operating Expenses | | Research Development | 13,100 | 10,700 | 10,600 | 12,400 | | Selling General and Administrative | 98,400 | 91,800 | 90,800 | 93,900 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 141,200 | 145,100 | 107,400 | 140,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,700) | 9,400 | (6,100) | (4,900) | | Earnings Before Interest And Taxes | 131,100 | 158,900 | 101,300 | 135,500 | | Interest Expense | 2,100 | 2,300 | 2,100 | 7,300 | | Income Before Tax | 129,000 | 156,600 | 99,200 | 128,200 | | Income Tax Expense | 41,600 | 45,500 | 27,700 | 34,300 | | Minority Interest | (1,600) | 200 | (200) |
-
| | | | Net Income From Continuing Ops | 91,800 | 106,900 | 71,300 | 93,900 | | | Non-recurring Events | | Discontinued Operations | 400 | 100 | (300) | (2,600) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 90,600 | 107,000 | 71,000 | 91,300 | | Preferred Stock And Other Adjustments | 1,000 | (1,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $91,600 | $106,000 | $71,000 | $91,300 |
|
0.01% Nasdaq 
0.22%
Income Statement
